Olaplex (NASDAQ:OLPX) Stock Rating Lowered by Canaccord Genuity Group

Olaplex (NASDAQ:OLPXGet Free Report) was downgraded by investment analysts at Canaccord Genuity Group from a “strong-buy” rating to a “hold” rating in a note issued to investors on Thursday,Zacks.com reports.

Several other equities research analysts have also commented on OLPX. Jefferies Financial Group reissued a “buy” rating on shares of Olaplex in a research report on Wednesday, March 4th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Olaplex in a report on Thursday, January 22nd. Northland Securities downgraded Olaplex from a “strong-buy” rating to a “hold” rating in a report on Thursday. Evercore set a $2.50 target price on Olaplex in a research report on Friday, March 6th. Finally, Telsey Advisory Group raised their price target on Olaplex from $2.00 to $2.06 and gave the stock a “market perform” rating in a research note on Friday. One research analyst has rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $1.89.

Read Our Latest Report on Olaplex

Olaplex Stock Performance

Shares of Olaplex stock opened at $2.02 on Thursday. The company has a quick ratio of 4.00, a current ratio of 4.58 and a debt-to-equity ratio of 0.40. Olaplex has a 52 week low of $0.99 and a 52 week high of $2.02. The firm’s 50 day moving average is $1.51 and its two-hundred day moving average is $1.36. The firm has a market capitalization of $1.35 billion, a P/E ratio of -202.00 and a beta of 2.24.

Olaplex (NASDAQ:OLPXGet Free Report) last issued its quarterly earnings data on Thursday, March 5th. The company reported $0.01 earnings per share for the quarter, hitting the consensus estimate of $0.01. Olaplex had a negative net margin of 2.19% and a positive return on equity of 1.07%. The business had revenue of $105.12 million during the quarter, compared to the consensus estimate of $104.21 million. During the same quarter in the previous year, the firm earned $0.01 EPS. The company’s revenue was up 4.4% compared to the same quarter last year. Research analysts forecast that Olaplex will post 0.1 EPS for the current fiscal year.

Insider Buying and Selling

In other news, General Counsel John C. Duffy sold 34,962 shares of the company’s stock in a transaction dated Thursday, March 12th. The shares were sold at an average price of $1.26, for a total value of $44,052.12. Following the completion of the sale, the general counsel directly owned 982,855 shares of the company’s stock, valued at approximately $1,238,397.30. This represents a 3.43% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Trisha L. Fox sold 25,421 shares of the stock in a transaction dated Thursday, March 12th. The stock was sold at an average price of $1.26, for a total transaction of $32,030.46. Following the sale, the insider owned 1,080,363 shares of the company’s stock, valued at $1,361,257.38. This trade represents a 2.30% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 215,442 shares of company stock worth $271,457 in the last 90 days. Company insiders own 4.30% of the company’s stock.

Hedge Funds Weigh In On Olaplex

Several institutional investors have recently added to or reduced their stakes in OLPX. Fund 1 Investments LLC purchased a new stake in Olaplex during the 4th quarter valued at approximately $1,023,000. Abel Hall LLC purchased a new position in shares of Olaplex in the 4th quarter valued at approximately $27,000. Jump Financial LLC grew its stake in shares of Olaplex by 193.7% in the 4th quarter. Jump Financial LLC now owns 29,800 shares of the company’s stock valued at $40,000 after purchasing an additional 19,653 shares during the last quarter. Russell Investments Group Ltd. increased its holdings in shares of Olaplex by 284.7% in the fourth quarter. Russell Investments Group Ltd. now owns 1,909,836 shares of the company’s stock valued at $2,559,000 after purchasing an additional 1,413,423 shares during the period. Finally, Barclays PLC increased its holdings in shares of Olaplex by 9.5% in the fourth quarter. Barclays PLC now owns 245,088 shares of the company’s stock valued at $328,000 after purchasing an additional 21,292 shares during the period. Institutional investors and hedge funds own 87.37% of the company’s stock.

Key Stories Impacting Olaplex

Here are the key news stories impacting Olaplex this week:

  • Positive Sentiment: Henkel agreed to acquire Olaplex for $2.06 per share (≈$1.4 billion), a ~55% premium to the pre-announcement close; the deal is being pitched as enabling greater investment and distribution for the brand. OLAPLEX to be Acquired by Henkel for $1.4 Billion
  • Positive Sentiment: Heavy bullish activity and strong market reaction: premarket headlines and commentary noted a large surge after the announcement, and unusual options activity (large buy of calls) signaled speculative and takeover-arbitrage positioning. Wall Street Breakfast Podcast: Henkel Adds Shine With Olaplex
  • Neutral Sentiment: Small analyst adjustments: Telsey Advisory Group raised its price target marginally to $2.06 and kept a “market perform” rating — a modest validation of the deal price but not a strong new bullish signal. Benzinga
  • Negative Sentiment: Multiple shareholder-law firms have launched investigations into whether Olaplex shareholders received a fair price or whether there were breaches of fiduciary duty in connection with the sale — this raises litigation risk and could complicate closing/timing. M&A Class Action Firm Announces Investigation Ademi Firm Investigates Fair Price
  • Negative Sentiment: Critical analysis and a downgrade: commentary pieces flagged negative implications of the sale for certain stakeholders, and Northland downgraded the stock from “strong-buy” to “hold” — both could reduce enthusiasm among some investors. Henkel Buys Olaplex – Implications Are Negative Zacks (Northland downgrade)

About Olaplex

(Get Free Report)

Olaplex, Inc (NASDAQ: OLPX) is a specialty haircare company known for its patented bond-building technology designed to repair and strengthen hair from within. The company’s core offerings encompass a range of professional salon treatments and at-home maintenance products that target chemical damage, breakage and split ends. Olaplex formulations are built around a proprietary active ingredient that works at the molecular level to rebuild disulfide bonds broken during bleaching, coloring and heat styling processes.

Founded in 2014 and headquartered in Irvine, California, Olaplex initially gained traction among high-end salons before expanding into broader retail channels.

Featured Stories

Analyst Recommendations for Olaplex (NASDAQ:OLPX)

Receive News & Ratings for Olaplex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olaplex and related companies with MarketBeat.com's FREE daily email newsletter.